Physician profile
Scott A Kellner
NPI 1437192077
$282.88
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.81 · 2020: $12.99 · 2021: $12.25 · 2022: $138 · 2023: $48.54 · 2024: $43.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $137.76 | 2022 | |
| Novo Nordisk INC | $48.54 | 2023 | Wegovy |
| Merck Sharp & Dohme LLC | $24.92 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $21.19 | 2024 | Airsupra |
| Ultragenyx Pharmaceutical INC. | $15.14 | 2019 | |
| Hologic Sales and Service, LLC | $13.57 | 2024 | Thinprep 2000 Processor, Aptima |
| Sanofi Pasteur INC. | $12.99 | 2020 | |
| Dynavax Technologies Corporation | $6.37 | 2024 | Heplisav-B |
| Organon LLC | $2.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kellner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.